Tessa
is a Singapore-based biotechnology company that develops and commercializes T-cell therapies for the treatment of cancer... Read moreTessa
is a Singapore-based biotechnology company that develops and commercializes T-cell therapies for the treatment of cancer... Read more
News
Jul 06, 2023
Endpoints News
Tessa: Singapore cancer cell therapy startup Tessa Therapeutics to shut down
Jun 17, 2023
Life Care News
Tessa: Tessa Therapeutics Announces Positive Results from CD30
May 30, 2023
Benzinga
Tessa: Tessa Therapeutics' Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano
Mar 09, 2023
Pharamceutical Technology
Tessa: Tessa, US NCI sign agreement to assess TT11X for non-Hodgkin lymphoma
Mar 09, 2023
Pharmabiz
Tessa: Tessa inks CRADA with US National Cancer Institute to investigate TT11X in several subtypes of NHL
Mar 08, 2023
Life Care News
Tessa: Tessa Therapeutics Enters into Cooperative Research and
Jan 03, 2023
Life Care News
Tessa: Tessa Therapeutics Provides Strategic Outlook and Corporate
Dec 13, 2022
Life Care News
Tessa: Tessa Therapeutics Announces Updated Safety, Efficacy and
Nov 08, 2022
FirstWord Pharma
Tessa: Tessa Therapeutics, Baylor College of Medicine Execute Agreement For Global Commercial Rights to 'Off-the-Shelf' CAR-T Platform
Nov 03, 2022
FinanzNachrichten
Tessa: Tessa Therapeutics Ltd: Tessa Therapeutics Announces Three Abstracts Highlighting Data from Autologous and Allogeneic Cell Therapy Programs Accepted for Presentation at 64th ASH Annual Meeting and Exposition
